 Jounce Therapeutics Inc NASDAQ:JNCE Director Barbara Gayle Duncan sold 10,000 shares of the firms stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of 10.00, for a total value of 100,000.00. Following the completion of the sale, the director now directly owns 10,000 shares in the company, valued ... 